UBiome
| Company type | Private |
|---|---|
| Industry | Biotechnology |
| Founded | 2012 |
| Founder | Zachary Apte, Jessica Richman |
| Defunct | 2019 |
| Fate | Bankruptcy in 2019 after federal fraud charges in 2021. Founders are FBI fugitives. |
| Headquarters | , |
| Products |
|
| Website | ubiome.com (archived link) |
uBiome, Inc. was an American biotechnology company based in San Francisco that developed technology to sequence the human microbiome. Founded in 2012, the company filed for bankruptcy in 2019 following an FBI raid in an investigation over possible insurance fraud involving the US health insurance program Medicare.
In 2021, the Securities and Exchange Commission charged two of the cofounders (Jessica Richman and Zachary Apte) with defrauding investors. The couple were also charged with federal crimes including conspiracy to commit fraud and money laundering. Since 2021, the FBI has considered the founders to be fugitives.